Literature DB >> 23446680

Brain β-amyloid load approaches a plateau.

Clifford R Jack1, Heather J Wiste, Timothy G Lesnick, Stephen D Weigand, David S Knopman, Prashanthi Vemuri, Vernon S Pankratz, Matthew L Senjem, Jeffrey L Gunter, Michelle M Mielke, Val J Lowe, Bradley F Boeve, Ronald C Petersen.   

Abstract

OBJECTIVE: To model the temporal trajectory of β-amyloid accumulation using serial amyloid PET imaging.
METHODS: Participants, aged 70-92 years, were enrolled in either the Mayo Clinic Study of Aging (n = 246) or the Mayo Alzheimer's Disease Research Center (n = 14). All underwent 2 or more serial amyloid PET examinations. There were 205 participants classified as cognitively normal and 55 as cognitively impaired (47 mild cognitive impairment and 8 Alzheimer dementia). We measured baseline amyloid PET-relative standardized uptake values (SUVR) and, for each participant, estimated a slope representing their annual amyloid accumulation rate. We then fit regression models to predict the rate of amyloid accumulation given baseline amyloid SUVR, and evaluated age, sex, clinical group, and APOE as covariates. Finally, we integrated the amyloid accumulation rate vs baseline amyloid PET SUVR association to an amyloid PET SUVR vs time association.
RESULTS: Rates of amyloid accumulation were low at low baseline SUVR. Rates increased to a maximum at baseline SUVR around 2.0, above which rates declined-reaching zero at baseline SUVR above 2.7. The rate of amyloid accumulation as a function of baseline SUVR had an inverted U shape. Integration produced a sigmoid curve relating amyloid PET SUVR to time. The average estimated time required to travel from an SUVR of 1.5-2.5 is approximately 15 years.
CONCLUSION: This roughly 15-year interval where the slope of the amyloid SUVR vs time curve is greatest and roughly linear represents a large therapeutic window for secondary preventive interventions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23446680      PMCID: PMC3653215          DOI: 10.1212/WNL.0b013e3182840bbe

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Authors:  Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

2.  Longitudinal change of biomarkers in cognitive decline.

Authors:  Raymond Y Lo; Alan E Hubbard; Leslie M Shaw; John Q Trojanowski; Ronald C Petersen; Paul S Aisen; Michael W Weiner; William J Jagust
Journal:  Arch Neurol       Date:  2011-06-13

Review 3.  Amyloid-dependent and amyloid-independent stages of Alzheimer disease.

Authors:  Bradley T Hyman
Journal:  Arch Neurol       Date:  2011-04-11

4.  Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias.

Authors:  Victor L Villemagne; Kevin Ong; Rachel S Mulligan; Gerhard Holl; Svetlana Pejoska; Gareth Jones; Graeme O'Keefe; Uwe Ackerman; Henri Tochon-Danguy; J Gordon Chan; Cornelia B Reininger; Lueder Fels; Barbara Putz; Beate Rohde; Colin L Masters; Christopher C Rowe
Journal:  J Nucl Med       Date:  2011-07-15       Impact factor: 10.057

5.  Longitudinal patterns of β-amyloid deposition in nondemented older adults.

Authors:  Jitka Sojkova; Yun Zhou; Yang An; Michael A Kraut; Luigi Ferrucci; Dean F Wong; Susan M Resnick
Journal:  Arch Neurol       Date:  2011-05

6.  Resolving controversies on the path to Alzheimer's therapeutics.

Authors:  Dennis J Selkoe
Journal:  Nat Med       Date:  2011-09-07       Impact factor: 53.440

7.  In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults.

Authors:  Jitka Sojkova; Ira Driscoll; Diego Iacono; Yun Zhou; Kari-Elise Codispoti; Michael A Kraut; Luigi Ferrucci; Olga Pletnikova; Chester A Mathis; William E Klunk; Richard J O'Brien; Dean F Wong; Juan C Troncoso; Susan M Resnick
Journal:  Arch Neurol       Date:  2011-02

8.  Use of florbetapir-PET for imaging beta-amyloid pathology.

Authors:  Christopher M Clark; Julie A Schneider; Barry J Bedell; Thomas G Beach; Warren B Bilker; Mark A Mintun; Michael J Pontecorvo; Franz Hefti; Alan P Carpenter; Matthew L Flitter; Michael J Krautkramer; Hank F Kung; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Eric P Reiman; P Eric M Reiman; Simone P Zehntner; Daniel M Skovronsky
Journal:  JAMA       Date:  2011-01-19       Impact factor: 56.272

9.  Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition.

Authors:  Prashanthi Vemuri; Stephen D Weigand; Scott A Przybelski; David S Knopman; Glenn E Smith; John Q Trojanowski; Leslie M Shaw; Charlie S Decarli; Owen Carmichael; Matt A Bernstein; Paul S Aisen; Michael Weiner; Ronald C Petersen; Clifford R Jack
Journal:  Brain       Date:  2011-04-07       Impact factor: 13.501

10.  Amyloid-β associated cortical thinning in clinically normal elderly.

Authors:  J Alex Becker; Trey Hedden; Jeremy Carmasin; Jacqueline Maye; Dorene M Rentz; Deepti Putcha; Bruce Fischl; Douglas N Greve; Gad A Marshall; Stephen Salloway; Donald Marks; Randy L Buckner; Reisa A Sperling; Keith A Johnson
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

View more
  171 in total

1.  Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.

Authors:  Jon B Toledo; Henrik Zetterberg; Argonde C van Harten; Lidia Glodzik; Pablo Martinez-Lage; Luisella Bocchio-Chiavetto; Lorena Rami; Oskar Hansson; Reisa Sperling; Sebastiaan Engelborghs; Ricardo S Osorio; Hugo Vanderstichele; Manu Vandijck; Harald Hampel; Stefan Teipl; Abhay Moghekar; Marilyn Albert; William T Hu; Jose A Monge Argilés; Ana Gorostidi; Charlotte E Teunissen; Peter P De Deyn; Bradley T Hyman; Jose L Molinuevo; Giovanni B Frisoni; Gurutz Linazasoro; Mony J de Leon; Wiesje M van der Flier; Philip Scheltens; Kaj Blennow; Leslie M Shaw; John Q Trojanowski
Journal:  Brain       Date:  2015-07-27       Impact factor: 13.501

Review 2.  Suspected non-Alzheimer disease pathophysiology--concept and controversy.

Authors:  Clifford R Jack; David S Knopman; Gaël Chételat; Dennis Dickson; Anne M Fagan; Giovanni B Frisoni; William Jagust; Elizabeth C Mormino; Ronald C Petersen; Reisa A Sperling; Wiesje M van der Flier; Victor L Villemagne; Pieter J Visser; Stephanie J B Vos
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

Review 3.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  Biochim Biophys Acta       Date:  2013-09-23

4.  Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories.

Authors:  Brian J Lopresti; Elizabeth M Campbell; Zheming Yu; Stewart J Anderson; Ann D Cohen; Davneet S Minhas; Beth E Snitz; Sarah K Royse; Carl R Becker; Howard J Aizenstein; Chester A Mathis; Oscar L Lopez; William E Klunk; Dana L Tudorascu
Journal:  Neurobiol Aging       Date:  2020-05-31       Impact factor: 4.673

Review 5.  Alzheimer disease therapy--moving from amyloid-β to tau.

Authors:  Ezio Giacobini; Gabriel Gold
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

6.  Predicting Regional Pattern of Longitudinal β-Amyloid Accumulation by Baseline PET.

Authors:  Tengfei Guo; Matthias Brendel; Timo Grimmer; Axel Rominger; Igor Yakushev
Journal:  J Nucl Med       Date:  2016-10-06       Impact factor: 10.057

7.  The transitional association between β-amyloid pathology and regional brain atrophy.

Authors:  Philip S Insel; Niklas Mattsson; Michael C Donohue; R Scott Mackin; Paul S Aisen; Clifford R Jack; Leslie M Shaw; John Q Trojanowski; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2014-12-09       Impact factor: 21.566

Review 8.  Emerging biomarkers in cognition.

Authors:  Meredith Wicklund; Ronald C Petersen
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

9.  Nonlinear Distributional Mapping (NoDiM) for harmonization across amyloid-PET radiotracers.

Authors:  Michael J Properzi; Rachel F Buckley; Jasmeer P Chhatwal; Michael C Donohue; Cristina Lois; Elizabeth C Mormino; Keith A Johnson; Reisa A Sperling; Aaron P Schultz
Journal:  Neuroimage       Date:  2018-11-17       Impact factor: 6.556

10.  Pittsburgh Compound-B (PiB) binds amyloid β-protein protofibrils.

Authors:  Ghiam Yamin; David B Teplow
Journal:  J Neurochem       Date:  2016-12-12       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.